News: Thermo Fisher Scientific Inc (TMO)

TMO on New York Consolidated

128.45USD
19 Dec 2014
Price Change (% chg)

$0.93 (+0.73%)
Prev Close
$127.52
Open
$127.16
Day's High
$129.29
Day's Low
$127.07
Volume
3,121,010
Avg. Vol
1,944,588
52-wk High
$129.77
52-wk Low
$105.93

Search Stocks
Select another date:

Mon, Nov 17 2014

Fitch Rates Thermo Fisher's EUR Snr Notes 'BBB'; Outlook Negative

(The following statement was released by the rating agency) NEW YORK, November 17 (Fitch) Fitch Ratings has assigned a 'BBB' rating to Thermo Fisher Scientific's (Thermo Fisher) Euro denominated 640 million senior notes. The Rating Outlook is Negative. The ratings apply to $14.5 billion of debt at Sept. 27, 2014. A full list of ratings follows at the end of this press release. Along with $800 million of senior notes issued earlier this month, the proceeds of the Euro denominated issue will

Fitch Rates Thermo Fisher's Proposed Notes 'BBB'; Outlook Remains Negative

(The following statement was released by the rating agency) NEW YORK, November 06 (Fitch) Fitch Ratings has assigned a 'BBB' rating to Thermo Fisher Scientific's (Thermo Fisher) proposed $800 million senior notes. The Rating Outlook is Negative. The ratings apply to $14.5 billion of debt at Sept. 27, 2014. A full list of ratings follows at the end of this press release. The proceeds of the proposed notes will be used to fund a portion of $3.1 billion of scheduled debt maturities in the nex

Late-summer 2015 too late for rate hike: Fed's Fisher

NEW YORK - Raising the U.S. Federal Reserve's key interest rate in late-summer of 2015, as financial markets generally expect, would be waiting too long, Dallas Fed President Richard Fisher said on Monday.

Late-summer 2015 too late for rate hike -Fed's Fisher

NEW YORK, Nov 3 - Raising the U.S. Federal Reserve's key interest rate in late-summer of 2015, as financial markets generally expect, would be waiting too long, Dallas Fed President Richard Fisher said on Monday.

Thermo Fisher pledges to fix glitch in drug analysis software

LONDON - Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.

Thermo Fisher pledges to fix glitch in drug analysis software

LONDON, Nov 3 - Thermo Fisher Scientific has pledged to correct a glitch in software used to analyse data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.

Thermo Fisher profit jumps but revenue disappoints, shares drop

- Thermo Fisher Scientific Inc , said quarterly profit rose nearly 49 percent, boosted by the acquisition of genetic testing company Life Technologies, but shares fell 3 percent as revenue growth disappointed investors.

UPDATE 1-Thermo Fisher profit jumps but revenue disappoints, shares drop

(New throughout, updates share price, adds details and analyst comments)

Thermo Fisher profit jumps as Life Tech buyout pays off

Oct 22 - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported an about 49 percent rise in quarterly profit as it benefited from the acquisition of genetic testing company Life Technologies.

BRIEF-Thermo Fisher Scientific Q3 adjusted earnings per share $1.71

* Q3 earnings per share $1.17; Q3 adjusted earnings per share $1.71; Q3 revenue up 31 percent to $4.17 billion

Select another date:
Search Stocks